Answers are grounded in this paper and cite their sources.
Generalised pustular psoriasis is a rare, unpredictable, and sometimes severe subtype of psoriasis whose treatment is hampered by a lack of consensus and standardised therapeutic guidelines. The recent recognition of the involvement of the innate interleukin (IL)‐1/IL‐36 pathway has allowed the development of new biologic drugs such as Spesolimab. We present the case of a woman with persistent generalised pustular psoriasis (GGP) who, after numerous failures with several systemic and biologic therapies, was treated with Spesolimab and showed a very rapid and sustained response over time.
No takes yet. Share an insight, caveat, or question.
Fernández‐Galván et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: